COVID-19 Vaccine Recipients Develop Rare Blood Disorder

A registered nurse prepares a COVID-19 vaccine in Los Angeles, Calif., on Feb. 10, 2021. (Mario Tama/Getty Images)

Fed­er­al author­i­ties are inves­ti­gat­ing after some COVID-19 vac­cine recip­i­ents have devel­oped the rare blood dis­or­der throm­bo­cy­tope­nia, with at least sev­er­al cas­es result­ing in death.

A Food and Drug Admin­is­tra­tion (FDA) spokesper­son told The Epoch Times via email that the agency is inves­ti­gat­ing and assess­ing the report­ed cases.

“At this time, we have not found a causal rela­tion­ship,” the spokesper­son said. “We will update the pub­lic as we learn more about these events.”

The blood dis­or­der was list­ed by the FDA last year as a pos­si­ble adverse event out­come from get­ting a COVID-19 vac­cine, along­side oth­er seri­ous adverse events like Guil­lain-Bar­ré syn­drome and death.

Sev­er­al dozen case reports of post-vac­ci­na­tion throm­bo­cy­tope­nia have been sub­mit­ted to the Vac­cine Adverse Event Report­ing Sys­tem (VAERS), a pas­sive report­ing sys­tem man­aged by the FDA and the Cen­ters for Dis­ease Con­trol and Pre­ven­tion. Approx­i­mate­ly 44.7 mil­lion dos­es of COVID-19 vac­cines have been admin­is­tered in the Unit­ed States as of Feb. 10.

ANNOUNCEMENT

Big Tech is at war with you! They don't want you to see the truth. Bookmark us and visit daily. 

JOIN OUR POPULAR NEWSLETTER

Send this to a friend